THE
ANTIVENOM
COMPANY™

We produce the latest generation
of highly specific biological polyvalent antivenoms

This could be the new Treatment developed in Mexico to neutralize COVID

To stop anyone from suffering or dying as a consequence of animal envenoming

OUR MISSION

We believe that no one should suffer or die as a consequence of animal envenoming. For this reason, we have developed a unique and original platform to make safe, effective, and non-cold chain dependent antivenoms available at a fair price.

We are eager to be part of the solution. We work close to patients along with the medical community, governments, and many international organizations and institutions in order to improve the access to antivenoms and the care for people affected by animal envenoming.

We currently distribute and commercialize our products mainly in Africa and Middle East and we are developing new antivenoms for other regions.

We perform our mission passionately and committed to the integrity wherever we operate. We reflect these values in our products, services, and communication while interacting with people.

Our strategy and products are aligned with the WHO plan to reduce the effects of animal envenoming.

OUR PRODUCTS

At Inosan Biopharma we develop and distribute
the latest generation antivenoms that meet the
highest manufacturing standards

Broad regional coverage of medically important species
Highly purified
High neutralizing capacity with low total protein content
No preservatives
Injectable lyophilizates

Inoserp^TM
PAN-AFRICA

Is a polyvalent equine antivenom specifically indicated for the treatment of sub-Saharan African snake bites. It is a sterile, highly purified lyophilized preparation of equine F(ab´)₂ immunoglobulin fragments neutralizing with high specificity the venoms of the following species: Viperidae: Echis ocellatus, Echis leucogaster, Echis pyramidum, Bitis arietans, Bitis rhinoceros, Bitis nasicornis, Bitis gabonica; and Elapidae: Dendroaspis polylepis, Dendroaspis viridis, Dendroaspis angusticeps, Dendroaspis jamesoni, Naja nigricollis, Naja melanoleuca, Naja haje, Naja pallida, Naja nubiae, Naja katiensis and Naja senegalensis.

Inoserp^TM
MENA

Is a polyvalent equine antivenom specifically indicated for the treatment of sub- Middle East and North African snake bites. It is a sterile, highly purified lyophilized preparation of equine F(ab´)₂ immunoglobulin fragments neutralizing with high specificity the venoms of the following species: Viperidae: Bitis arietans, Cerastes cerastes, Cerastes gasperettii, Cerastes vipera, Daboia deserti, Daboia mauritanica, Daboia palaestinae, Echis carinatus sochureki, Echis coloratus, Echis khosatzkii, Echis leucogaster, Echis megalocephalus, Echis omanensis, Echis pyramidum, Macrovipera lebetina obtusa, Macrovipera Iebetina transmediterranea, Macrovipera Iebetina turanica, Montivipera bornmuelleri, Montivipera raddei kurdistanica, Pseuocerastes fieldi, Pseudocerastes persicus, Vipera latastei and Elapidae: Naja haje, Naja nubiae, Naja pallida and Walterinnesia aegyptia.

Inoscorpi^TM
MENA

Is a polyvalent equine antivenom specifically indicated for the treatment of Middle East and North African scorpion stings. It is a sterile, highly purified lyophilized preparation of equine F(ab´)₂ immunoglobulin fragments neutralizing with high specificity the venoms of the following species: Androctonus australis, Androctonus mauritanicus, Androctonus crassicauda, Androctonus amourexi, Androctonus bicolor, Buthus occitanus, Buthus mardochei, Leiurus quinquestriatus quinquestriatus, Leiurus quinquestriatus hebraeus, Buthus Tunetanus.

Technology driven solutions for the present and constantly evolving for the future.

At Inosan Biopharma, we have transformed antiserum to very pure antigen-binding immunoglobulin fragments with high neutralizing potency in full compliance with international GMPs requirements.

THE TEAM